Oncotelic Therapeutics, Inc. Convertible Debt, Noncurrent
Oncotelic Therapeutics, Inc. (OTLC) had Convertible Debt, Noncurrent of $1.85 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:ConvertibleDebtNoncurrent · last filed 2026-08-13
- 2026-06-30: Convertible Debt, Noncurrent $1.85M.
- 2026-03-31: Convertible Debt, Noncurrent $1.79M.
- 2025-12-31: Convertible Debt, Noncurrent $1.66M.
- 2023-12-31: Convertible Debt, Noncurrent $1.90M.
| Period end | Convertible Debt, Noncurrent |
|---|---|
| 2026-06-30 | $1.85M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.79M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.66M 10-Q · filed 2026-08-13 |
| 2023-12-31 | $1.90M 10-K · filed 2025-04-15 |